1 Oversold Stock Set for a Comeback and 2 That UnderwhelmThe past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet...
The 5 Most Interesting Analyst Questions From Insulet’s Q1 Earnings CallInsulet’s first quarter was marked by robust revenue growth, driven by continued adoption of its Omnipod 5 insulin delivery system across both U.S. and inter...
Why Insulet (PODD) Stock Is Trading Up TodayWhat Happened? Shares of insulin delivery company Insulet Corporation (
NASDAQ:PODD) jumped 3.4% in the afternoon session after Benchmark initiated coverage o...
3 Quality Compounders to Research FurtherQuality compounders are flywheels. Said differently, they’re businesses that generate heaps of profits and consistently reinvest them to produce even more pr...
Insulet (NASDAQ:PODD) Reports Upbeat Q1 CY2026, Stock SoarsInsulin delivery company Insulet Corporation (
NASDAQ:PODD) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 33.9% year on...
Earnings To Watch: Insulet (PODD) Reports Q1 Results TomorrowInsulin delivery company Insulet Corporation (
NASDAQ:PODD) will be reporting earnings this Wednesday morning. Here’s what investors should know. Insulet beat...
1 Oversold Stock Primed to Rebound and 2 We IgnoreHitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a co...
2 of Wall Street’s Favorite Stocks for Long-Term Investors and 1 We Turn DownThe stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
2 High-Flying Stocks to Own for Decades and 1 We Turn DownExpensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lo...
Insulet (PODD): 3 Reasons We Love This StockWhat a brutal six months it’s been for Insulet. The stock has dropped 33.8% and now trades at $204.57, rattling many shareholders. This may have investors wo...
Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares SoaringShares of Eli Lilly and Company (
NYSE: LLY) surged 3.8% on Wednesday following the milestone FDA approval of Foundayo (orforglipron), the first once-daily oral weight-loss pill that does not require strict fasting or water intake restrictions. The approval, which came months ahead of initial analyst expectations, marks a pivotal
Winners And Losers Of Q4: Insulet (NASDAQ:PODD) Vs The Rest Of The Patient Monitoring StocksWrapping up Q4 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including Insulet (
NASDAQ:PODD) and its peers. Patient m...
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To KnowWhat Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
